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Abstract
Our objective was to measure obstetric outcomes and delivery-re-
lated health care utilization and costs among pregnant women with
multiple chronic conditions. We used 2013–2014 data from the
National Inpatient Sample to measure obstetric outcomes and de-
livery-related health care utilization and costs among women with
no chronic conditions, 1 chronic condition, and multiple chronic
conditions. Women with multiple chronic conditions were at signi-
ficantly higher risk than women with 1 chronic condition or no
chronic  conditions  across  all  outcomes  measured.  High-value
strategies are needed to improve birth outcomes among vulner-
able mothers and their infants.
Objective
Complications from chronic conditions are a key driver of rising
obstetric morbidity and mortality in the United States (1). The pre-
valence of chronic conditions, including multiple chronic condi-
tions (MCCs), continues to rise among childbearing women (2,3).
MCCs, defined as 2 or more chronic conditions, are associated
with worse health outcomes, including death, and higher levels of
health care utilization and costs among the non-pregnant adult
population (4). Understanding these data influenced the develop-
ment of high-value programs that improved health outcomes and
lowered costs in high-risk, high-cost populations (5). Our object-
ive was to measure obstetric outcomes and delivery-related health
care utilization and costs among pregnant women with MCCs.
Methods
We  conducted  a  retrospective,  cross-sectional  analysis  of
2013–2014 data from the National Inpatient Sample (6), a nation-
ally representative sample of hospital discharges in the United
States. Deliveries were identified by using previous methods (7),
and data for chronic conditions were abstracted by using relevant
codes from the International Classification of Diseases, Ninth Re-
vision, Clinical Modification (ICD-9-CM) (8) (Box). We included
8 chronic conditions that are prevalent in the childbearing popula-
tion and associated with obstetric morbidity and mortality: chron-
ic respiratory disease, chronic hypertension, substance use dis-
orders, pre-existing diabetes, chronic heart disease, chronic kid-
ney disease, human immunodeficiency virus/acquired immune de-
ficiency syndrome, and chronic liver disease (3,9).
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Box. International Classification of Diseases, Ninth Revision, Clinical
Modification Codes Used in Study
Condition Codes
Chronic respiratory
disease
491.x–496.x
Chronic hypertension 401.x–405.x, 642.0x, 642.1x, 642.2x, 642.7x
Substance use disorders 303.01, 303.02, 303.03, 304.x, 305.0x,
305.2x–305.9x, 648.3x
Pre-existing diabetes 249.x, 250.x, 648.0x
Chronic heart disease 412.x–414.x, 394.x-397.x, 424.x, 428.22,
428.23, 428.32, 428.33, 428.42, 428.43,
745.0x–747.4x, 648.5x
Chronic renal disease 581.x-583.x, 585.x, 587.x, 588.x, 646.2x
Chronic liver disease 571.x, 572.x
Human
immunodeficiency virus/
acquired immune
deficiency syndrome
042.x, V08.x
Obstetric outcomes included preterm delivery, cesarean delivery,
and severe maternal morbidity and mortality. Preterm delivery was
measured by using ICD-9-CM code 644.21, and cesarean delivery
was measured by using ICD-9-CM codes 740.x,  741.x,  742.x,
744.x, and 749.9. Severe maternal morbidity was measured by us-
ing standardized diagnosis and procedure codes outlined by the
Centers for Disease Control and Prevention (10). Health care util-
ization measures included need for hospital transfer and length of
stay. Delivery-associated hospital charges from the Healthcare
Cost and Utilization Project’s cost-to-charge ratio files were used
to calculate costs. Charge and cost estimates were adjusted for in-
flation to 2014 dollars.
We used multivariable logistic regression models to estimate ob-
stetric outcomes. We generated estimates for hospital  transfer,
length of stay, and costs by using multivariable Poisson regres-
sion models,  because these data were not normally distributed
(Shapiro–Wilk test, P < .001 for each). All estimates were popula-
tion averages generated with post-regression predictive margins
and tabulated per 100 delivery hospitalizations. Models were ad-
justed for age, rural versus urban residence, primary insurance
payer, median household income for the patient’s zip code, and
hospital region. In sensitivity analyses of our cost estimates, we
controlled for obstetric outcomes to isolate the independent associ-
ation between MCCs and cost. We used complete case analysis
rather than imputation, because less than 3% of observations had
missing data. All analyses were conducted using STATA version
14.2 (StataCorp LLC). Our analysis of de-identified data was ex-
empt from review by the study site’s institutional review board.
Results
Our sample consisted of 1,508,413 unweighted delivery hospital-
izations, representing 7,542,063 weighted delivery hospitaliza-
tions occurring nationally in 2013–2014. We identified MCCs in
12,567 unweighted delivery hospitalizations (weighted percentage,
0.83%; 95% confidence interval [CI], 0.80%–0.86%) and 1 chron-
ic  condition  in  127,350  unweighted  delivery  hospitalizations
(weighted percentage, 8.4%; 95% CI, 8.3%–8.6%). Women with
MCCs were older than women with 1 chronic condition or no
chronic conditions (30.2 y, 28.5 y, and 28.2 y, respectively) (Ta-
ble 1). A higher proportion of women with MCCs (63.8%) had
Medicaid as their primary payer compared with the proportion of
women with 1 chronic condition (53.2%) or no chronic conditions
(42.9%).
Among pregnant women hospitalized for obstetric delivery, rates
of preterm delivery, cesarean delivery, and severe maternal mor-
bidity and mortality were significantly higher among women with
MCCs than among women with no chronic condition or 1 chronic
condition (Table 2). The rate of severe maternal morbidity and
mortality among women with MCCs (6.4 per 100 delivery hospit-
alizations) was nearly 4 times higher than among women with no
chronic conditions (1.7 per 100 delivery hospitalizations). Simil-
arly, health care utilization and costs were highest among women
with MCCs compared with those with no chronic condition or 1
chronic condition, even after controlling for obstetric outcomes
and length of stay (Table 3). Women with 1 chronic condition
were also at significantly higher risk than women with no chronic
conditions across each outcome measured.
Discussion
In this nationally representative sample of delivery hospitaliza-
tions from 2013–2014, women with MCCs had worse health out-
comes, higher levels of health care utilization, and greater hospital
costs associated with obstetric delivery compared with women
with no chronic conditions or 1 chronic condition. In particular,
the rate of severe maternal morbidity and mortality was 276%
higher among women with MCCs than among women with no
chronic conditions. Hospital costs were highest among patients
with MCCs compared with those with no chronic condition or 1
chronic condition — even after even after controlling for obstetric
outcomes and length of stay. It is plausible that higher costs may
have resulted from greater use of consultative or social services,
data that were not captured by our methods.
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A limitation of our study design is that clinicians were likely to
document  ICD-9-CM codes  only  for  conditions  that  were  ad-
dressed during a delivery hospitalization. As such, our point estim-
ates of MCC prevalence are likely to be conservative.  For ex-
ample, some women with MCCs may have been misclassified as
having 1 chronic condition or no chronic conditions. Total costs
associated with MCCs are also likely to be larger than our estim-
ates. For example, women with MCCs had higher rates of preterm
delivery, and considerable neonatal costs are associated with pre-
term birth (11).
Our findings show that pregnant women with MCCs are a high-
risk, high-cost population. The strong association between MCCs
and worse delivery-related health outcomes found in our study
suggests that MCCs may contribute to the high levels of maternal
morbidity and mortality in the United States. MCCs also contrib-
ute significantly to the cost of delivery hospitalizations. Delineat-
ing the highest-risk and highest-cost combinations of conditions
may  provide  crucial  data  for  the  development  of  high-value
strategies  to  improve  birth  outcomes  among  these  vulnerable
mothers and their infants.
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Tables
Table 1. Characteristics of Patients With No Chronic Conditions, 1 Chronic Condition, and Multiple Chronic Conditions (Unweighted N = 1,508,413), National Inpa-
tient Sample, 2013–2014a
Characteristic
No Chronic Conditions
(n = 1,368,496)
1 Chronic Condition
(n = 127,350)
Multiple (≥2) Chronic Conditions
(n = 12,567)
Mean ageb, y 28.2 (28.1–28.3) 28.5 (28.5–28.6) 30.2 (30.0–30.3)
Payer
Medicaid 42.9 (42.1–43.7) 53.2 (52.3–54.1) 63.8 (62.5–65.1)
Private 51.3 (50.5–52.2) 42.4 (41.4–43.3) 32.2 (30.9–33.5)
Uninsured 5.8 (5.5–6.0) 4.4 (4.2–4.7) 4.0 (3.6–4.4)
Bottom income quartilec 27.1 (26.3–27.9) 33.4 (32.4–34.5) 40.4 (38.9–41.9)
Rural residence 14.1 (13.6–14.5) 14.6 (14.0–15.3) 13.7 (12.8–14.6)
Hospital region
Northeast 15.9 (15.2–16.7) 17.6 (16.6–18.7) 17.2 (15.7–18.8)
Midwest 21.2 (20.4–22.0) 22.1 (21.0–23.1) 22.2 (20.7–23.9)
South 38.4 (37.4–39.5) 38.3 (37.0–39.6) 39.9 (38.0–41.9)
West 24.5 (23.6–25.4) 22.0 (21.0–23.1) 20.6 (19.3–22.0)
a All data presented as weighted percentage (95% confidence interval) unless otherwise noted.
b Weighted mean (95% confidence interval).
c Patients living in a zip code with a median household income in the bottom national income quartile.
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Table 2. Weighted National Estimates of Delivery-Related Outcomes Among Patients With No Chronic Conditions, 1 Chronic Condition, and Multiple Chronic Condi-
tions, National Inpatient Sample, 2013–2014a
Outcome No Chronic Conditions 1 Chronic Condition Multiple (≥2) Chronic Conditions
Health outcomes
Preterm delivery (<37 weeks) 5.7 (5.6–5.7) 9.7 (9.5–10.0) 15.1 (14.4–15.9)
Cesarean delivery 31.9 (31.7–32.2) 41.2 (40.8–41.6) 53.3 (52.3–54.2)
Severe maternal morbidity and mortality 1.7 (1.7–1.7) 3.0 (2.8–3.1) 6.4 (5.9–6.8)
Health care use
Hospital transfer 1.1 (0.9–1.2) 2.0 (1.8–2.3) 3.5 (3.1–4.0)
Length of stay, in daysb 2.6 (2.6–2.6) 3.1 (3.1–3.2) 4.3 (4.2–4.3)
Health care expenditures, $c
Mean charges per delivery hospitalization 16,000 (16,000–17,000) 20,000 (19,000–20,000) 28,000 (27,000–29,000)
Mean cost per delivery hospitalization 4,500 (4,400–4,500) 5,600 (5,500–5,600) 7,700 (7,500–8,000)
a All data presented as rate per 100 delivery hospitalizations (95% confidence interval) unless otherwise noted. Adjusted for age, rural vs urban residence, payer,
national income quartile for zip code of residence, and hospital region.
b Weighted mean (95% confidence interval).
c Inflation-adjusted to 2014 US dollars.
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Table 3. Weighted National Estimates of Mean Cost (95% CI)a per Delivery Hospitalization Among Patients With No Chronic Condition, 1 Chronic Condition, and Mul-
tiple Chronic Conditions, National Inpatient Sample, 2013–2014
Model Adjustmentb No Chronic Conditions 1 Chronic Condition Multiple (≥2) Chronic Conditions
Severe maternal morbidity and mortality 4,500 (4,400–4,500) 5,500 (5,400–5,600) 7,300 (7,100–7,500)
Preterm delivery 4,500 (4,400–4,500) 5,500 (5,400–5,600) 7,400 (7,200–7,600)
Cesarean delivery 4,500 (4,400–4,600) 5,300 (5,200–5,400) 6,900 (6,700–7,100)
Length of stay 4,500 (4,400–4,500) 5,500 (5,400–5,600) 7,400 (7,200–7,600)
All outcomes 4,500 (4,500–4,600) 5,200 (5,100–5,200) 6,200 (6,000–6,400)
Abbreviation: CI, confidence interval.
a Inflation-adjusted to 2014 US dollars.
b In addition to the following demographic covariates: age, rural vs urban residence, payer, national income quartile for zip code of residence, and hospital region.
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